Search clinical trials for: FHD-286

Total 1648 results

Foghorn Therapeutics Inc.

Terminated

FHD-286 in Subjects With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

United States, Netherlands, France
Nanjing Medical University
Beijing Anzhen Hospital; Second Affiliated Hospital of Nanchang University

Recruiting

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V

Acute Aortic Syndrome | Aortic Dissectio

China
Fayoum University Hospital

Completed

The Ratio Of Femoral Vein Diameter To Femoral Artery Diameter With Pulse Pressure Variation As A Diagnostic Tool

Mechanically Ventilated Patients

Egypt
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury

Neurobehavioral Disinhibition

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Agitation in Participants With Dementia of the Alzheimer's Type

United States, Canada
Foghorn Therapeutics Inc.

Recruiting

FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies

Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic Leukemia

United States
Foghorn Therapeutics Inc.

Terminated

FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Advanced Synovial Sarcoma

United States, Spain, France, Italy
RWTH Aachen University
Heinrich-Heine University, Duesseldorf

Completed

Influence of Hemodialysis on Endothel-Depending Dilatation of Peripheral Arteries

Hemodialysis

Germany
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Guangdong Provincial Hospital of Traditional Chinese...

Completed

Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)

Obesity

China
Novartis Pharmaceuticals

Active, not recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) (LuMIERE)

Solid Tumor

United States
Design Therapeutics

Completed

Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia

Friedreich Ataxia

United States
Amgen

Completed

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

Asthma

United States
Becton, Dickinson and Company

Completed

Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Alopecia | Male Pattern Hair Loss

United States
Boehringer Ingelheim

Completed

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

Healthy
Mingzhi Zhang
Zhengzhou University

Unknown

Treatment of Primary CNS Lymphoma (FVD)

Primary CNS Lymphoma (PCNSL)

China
Swiss Federal Institute of Technology

Completed

Impact of Bean Polyphenols and Phytic Acid on Iron Absorption

Blood Iron Isotope Enrichment

Switzerland
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Cognitive Deficits in Schizophrenia

United States
SIGA Technologies
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers (SIGA-246-002)

Healthy

United States
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

Type2 Diabetes Mellitus
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Not yet recruiting

Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study) (TANDEM)

Healthy | Overweight and Obesity

United States
Charite University, Berlin, Germany

Completed

Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients (CONVINT)

Acute Renal Failure

Germany
Montana State University
Organic Advisory and Education Council

Completed

Impact of Beef on Metabolites and Inflammation

Healthy

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients

Cystic Fibrosis
Takeda
Takeda Development Center Americas, Inc.

Recruiting

First-in-Human Study of TAK-280 in Participants With Unresectable Locally Advanced or Metastatic Cancer

Unresectable Locally Advanced or Metastatic Cancer

United States, Australia
Groupe Francophone des Myelodysplasies

Active, not recruiting

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

France
Amgen

Completed

Study of AMG 256 in Adult Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Belgium, Spain, Australia
BeiGene

Completed

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Solid Tumors

China
Aprea Therapeutics

Completed

Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

Prostatic Neoplasms | Hematologic Neoplasms

Sweden
CytRx

Withdrawn

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients

Cystic Fibrosis
Children's Hospital Medical Center, Cincinnati

Completed

Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease

Congenital Heart Disease | Nutritional Failure

United States
Stanford University

Not yet recruiting

Examining Bluetooth Haptic Device Use for Pain and Anxiety Reduction in Vascular Access Procedures (VA+BHD)

Pain | Anxiety
Nottingham Trent University
Loughborough University

Completed

Fasted Evening Exercise: Performance and Compensatory Eating

Obesity

United Kingdom
Teijin America, Inc.
Parexel

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Boehringer Ingelheim

Completed

Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS

Healthy
Boehringer Ingelheim

Completed

Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis

Arthritis, Rheumatoid
Ruijin Hospital

Recruiting

a Feasibility Study of iHD-SRT for BM

Brain Metastases, Adult | Stereotactic Radiotherapy

China
University of British Columbia
University of Otago

Not yet recruiting

Brain Substrate Switch to Ketones and Lactate (BSS)

Metabolic Diseases | Aging Problems

Canada
University of Denver

Active, not recruiting

Fostering Healthy Futures for Teens: An RCT (FHF-T)

Risk Behavior | Child Abuse | Substance Use | Sexual Behavior | Mental Health Impairment | Adolescent Behavior | Delinquency | Educational Problems | Adolescent Development | Child Neglect | Child Maltreatment

United States
Oslo University Hospital
Central Hospital, Fredrikstad

Active, not recruiting

Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture

Achilles Tendon Rupture

Norway
AxioMed Spine Corporation

Unknown

Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease (FLD)

Degenerative Disc Disease (DDD)

United States, Germany
Lawson Health Research Institute

Completed

Families Defeating Diabetes (FDD)

Diabetes Prevention

Canada
Centre Hospitalier Universitaire de Saint Etienne
Association Française contre les Myopathies (AFM), Paris

Completed

Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program. (FSHD2)

Muscular Dystrophy, Facioscapulohumeral

France
Stony Brook University

Completed

Trans-anal Hemorrhoidal Dearterialization (THD) vs. Hemorrhoidectomy (THD)

Hemorrhoids

United States
Utah State University
Duke University; United States Department of Agriculture (USDA)

Recruiting

Beef and Plant Burger Metabolomics Study

Inflammatory Response

United States
Suzhou Kintor Pharmaceutical Inc,
Suzhou Koshine Biomedica, Inc.

Active, not recruiting

Phase III Study of KX-826 With Adult Male Patients With AGA

Androgenetic Alopecia

China
Hanmi Pharmaceutical Company Limited

Completed

Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Diabetes Mellitus

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Korea, Republic of

Search clinical trials for: FHD-286

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations